research Identification of drug-specific public TCR driving severe cutaneous adverse reactions
Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.
Los Angeles, CA, United States
Sanaa, Yemen
Pasir Gudang, Johor, Malaysia
Santiago, Chile
Dubai, United Arab Emirates
Tirana, Albania

